Cargando…
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
Autores principales: | Bartoletti, Michele, Azap, Ozlem, Barac, Aleksandra, Bussini, Linda, Ergonul, Onder, Krause, Robert, Martín-Quirós, Alejandro, Paño-Pardo, José Ramon, Power, Nicholas, Sibani, Marcella, Szabo, Balint, Tsiodras, Sotirios, Zollner-Schwetz, Ines, Rodriguez-Baño, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744251/ https://www.ncbi.nlm.nih.gov/pubmed/35026374 http://dx.doi.org/10.1016/j.cmi.2021.12.025 |
Ejemplares similares
-
ESCMID COVID-19 living guidelines: drug treatment and clinical management
por: Bartoletti, Michele, et al.
Publicado: (2022) -
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease
por: Bartoletti, Michele, et al.
Publicado: (2022) -
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!
por: Barac, Aleksandra, et al.
Publicado: (2022) -
The ESCMID ethics advisory committee (EEAC): purpose and challenges
por: Righi, Elda, et al.
Publicado: (2022) -
The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey
por: Altunsoy, Adalet, et al.
Publicado: (2011)